Paul Ehrlich Develops Salvarsan, the First Chemotherapy Drug
Poet involved
What happened
In 1909, Paul Ehrlich developed Salvarsan, the first modern chemotherapy drug specifically targeting the syphilis bacterium. This marked the beginning of a new era in pharmacological therapy, as Salvarsan represented a significant advancement in the treatment of infectious diseases. Ehrlich's work laid the groundwork for future developments in targeted therapies, influencing the fields of medicine and pharmacology.
Literary impact
Ehrlich's 'magic bullet' concept—a drug designed to target a specific pathogen—entered metaphorical language and influenced 20th-century modernist writing about precision, systems, and the mechanical body. This idea resonated in the works of poets like Ezra Pound, who examined the intersection of technology and humanity.
Source: Wikipedia
